ECTRIMS NeuroWebinars are designed to facilitate connectivity and enable the professional MS community to elevate topics of interest, navigate discussions around clinical research & practice, and drive the exposure and development of ideas and innovation. Our aim is to help build a community where participants are given their “own space” to share and present new research, insights and ideas.
Redefining How Multiple Sclerosis Is Classified: A New Framework
26 January 2023, 16:00-16:45 CET
Registration has closed.
Relapsing-remitting. Primary Progressive. Secondary Progressive. These are the primary descriptions used to define the various stages of multiple sclerosis. But what would happen if we moved away from such purely clinical descriptions, creating instead a new system based on underlying biology, rather than how the disease appears clinically?
In this ECTRIMS NeuroWebinar, an international panel of experts discuss their newly proposed “mechanism-driven” framework recently published in Lancet Neurology. The framework – developed under the auspices of the International Advisory Committee on Clinical Trials in MS, a group jointly sponsored by ECTRIMS and the US National MS Society – aims to better describe the disease course across the lifespan and lays the future groundwork for more personalised treatment options for people with MS.
The panel includes:
Moderated by Thomas Berger, Chair of the European Academy of Neurology (EAN) Scientific Committee, EAN Board Member and Professor of Neurology at MedUni Innsbruck.
This webinar is organised together with MS National Society and the European Academy of Neurology.
12-30 May 2022
Nursing and allied health (AH) professionals are vital to the treatment, care and support of people living with multiple sclerosis. Amid a rapidly changing backdrop of MS research and technological advances, staying up to date on the latest tools and strategies to assist MS patients is paramount to their wellbeing.
This webinar series aimed (i) to bring together nursing and AH professionals to discuss the latest advancements and developments impacting their daily work with MS patients, and (ii) to provide an open forum for them across Europe and North America to assist in sharing insight and experience.